FibroGen
Discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs. Learn more
Launch date
Employees
Market cap
AUD66.4m
Enterprise valuation
AUD75m (Public information from Sep 2024)
Share price
$0.416 FGEN
San Francisco California (HQ)
Authorizing premium user...